Oslo, 9 January 2025

Reference is made to the stock exchange announcement by Observe Medical ASA
("Observe Medical" or the "Company", OSE ticker: OBSVR) on 7 January 2025,
regarding, inter alia, the resolution of the general meeting to increase the
Company's share capital by NOK 1.30, through the issue of 5 new shares, each
with a nominal value of NOK 0.26, in order to facilitate for a share
consolidation (reverse share split) in the ratio 15:1.

The share capital increase has now been registered in the Norwegian Register of
Business Enterprises, and the Company's new share capital is NOK 75,107,806.80,
divided into 288,876,180 shares, each with a nominal value of NOK 0.26.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

This information is subject to the disclosure requirements pursuant to Section 5
-12 of the Norwegian Securities Trading Act.